BrightPath BiotherapeuticsLtd. (4594.TSE) Q3 2024 Earnings

9AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-4.24
-3.91
-3.58
-3.24

Details

Expected EPS
N/A
Actual EPS
-4.24422823872
Surprise EPS
-4.24
Surprise Percent
+∞%

Description

BrightPath BiotherapeuticsLtd. (4594.TSE) has reported earnings of -4.24422823872 per share for Q3 2024.

0 Comments

Share your thoughts